NASDAQ:SGRY - Surgery Partners Stock Price, Price Target & More

Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."

Surgery Partners declared that its board has initiated a share repurchase program on Saturday, December 16th 2017, which allows the company to buyback $50,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to purchase shares of its stock through open market purchases. Shares buyback programs are often a sign that the company's management believes its stock is undervalued.

Surgery Partners (NASDAQ:SGRY) posted its earnings results on Thursday, March, 1st. The company reported ($0.03) EPS for the quarter, missing analysts' consensus estimates of $0.08 by $0.11. The firm had revenue of $460.30 million for the quarter, compared to analyst estimates of $438.30 million. Surgery Partners had a negative net margin of 4.54% and a negative return on equity of 0.53%. Surgery Partners's quarterly revenue was up 50.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.35 earnings per share. View Surgery Partners' Earnings History.

Surgery Partners is scheduled to release their next quarterly earnings announcement on Monday, May, 7th 2018. View Earnings Estimates for Surgery Partners.

8 brokers have issued 12-month price objectives for Surgery Partners' stock. Their forecasts range from $15.00 to $19.00. On average, they expect Surgery Partners' share price to reach $17.6667 in the next year. View Analyst Ratings for Surgery Partners.

Some companies that are related to Surgery Partners include Repligen (RGEN), Sangamo Therapeutics (SGMO), Enanta Pharmaceuticals (ENTA), Abaxis (ABAX), Editas Medicine (EDIT), Xencor (XNCR), Innoviva (INVA), Akcea Therapeutics (AKCA), Atara Biotherapeutics (ATRA), Tivity Health (TVTY), Radius Health (RDUS), Momenta Pharmaceuticals (MNTA), Sirtex Medical (SRX), Mazor Robotics (MZOR), HMS (HMSY), Impax Laboratories (IPXL), Irhythm Technologies (IRTC) and Ensign Group (ENSG).

Headlines about SGRY stock have trended somewhat positive recently, Accern Sentiment Analysis reports. The research firm ranks the sentiment of press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Surgery Partners earned a coverage optimism score of 0.04 on Accern's scale. They also gave news stories about the company an impact score of 46.33 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

Surgery Partners' stock is owned by many different of institutional and retail investors. Top institutional shareholders include DOYLE MICHAEL THOMAS (6.10%) and DOYLE MICHAEL THOMAS (6.10%). Company insiders that own Surgery Partners stock include HIG Surgery Centers, Llc and Jennifer Baldock. View Institutional Ownership Trends for Surgery Partners.

Shares of SGRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of SGRY stock can currently be purchased for approximately $17.95.

Surgery Partners has a market capitalization of $849.49 million and generates $1.34 billion in revenue each year. The company earns $-52,980,000.00 in net income (profit) each year or ($0.84) on an earnings per share basis. Surgery Partners employs 10,600 workers across the globe.

Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The company can be reached via phone at 615-234-5900 or via email at [email protected]